Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Huang, Xinfang ^a   Guo, Yanzhi ^a   Bao, Chunde ^a   Shen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYCHLOROQUINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; PROLACTIN; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNORADIOMETRIC ASSAY; INTRACELLULAR SIGNALING; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROLACTIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SINGLE CELL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; B LYMPHOCYTE; BLOOD; IMMUNOLOGY; METABOLISM; METHODOLOGY; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADULT; B-LYMPHOCYTES; BIOLOGICAL MARKERS; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PHOSPHORYLATION; PROLACTIN; SIGNAL TRANSDUCTION; SINGLE-CELL ANALYSIS; STAT TRANSCRIPTION FACTORS; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES;

EID: 79960657991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021671     Document Type: Article

References (33)

1. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, et al. (1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147: 117-123.
2. Capper ER, Maskill JK, Gordon C, Blakemore AI, (2004) Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescentsystemic lupus erythematosus: Could longitudinal studies reveal patient subgroups of differing pathology? Clin Exp Immunol 138: 348-356.
3. Crow MK, (2005) Interferon pathway activation in systemic lupus erythematosus. Curr Rheumatol Rep 7: 463-468.
4. Remy I, Wilson IA, Michnick SW, (1999) Erythropoietin receptor activation by a ligand-induced conformation change. Science 283: 990-993.
5. Christian W, Schindler J, (2002) JAK-STAT signaling in human disease Clin. Invest 109: 1133-1137.
6. Harada T, Kyttaris V, Li Y, Juang YT, Wang Y, et al. (2007) Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration. Autoimmunity 40: 1-8.
7. Dong J, Wang QX, Zhou CY, Ma XF, Zhang YC, (2007) Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice. Lupus 16: 101-109.
8. Martinez-Lostao L, Ordi-Ros J, Balada E, Segarra-Medrano A, Majó-Masferrer J, et al. (2007) Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis. Lupus 16: 483-488.
9. Karonitsch T, Feierl E, Steiner CW, Dalwigk K, Korb A, et al. (2009) Activation of the Interferon- Signaling Pathway in Systemic Lupus Erythematosus Peripheral Blood Mononuclear Cells. Arthritis Rheum 60: 1463-1471.
10. Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud O, et al. (2004) Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118: 217-228.
11. Perez OD, Nolan GP, (2006) Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level. Immunological Reviews 210: 208-228.
12. Lee AW, Sharp ER, O'Mahony A, Rosenberg MG, Israelski DM, et al. (2008) phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection. J Virol 82: 3702-3712.
13. Krutzik PO, Trejo A, Schulz KR, Nolan GP, (2011) Phospho flow cytometry methods for the analysis of kinase signaling in cell lines and primary human blood samples. Methods Mol Biol 699: 179-202.
14. Lin CC, Huang WL, Su WP, Chen HH, et al. (2010) Single cell phospho-specific flow cytometry can detect dynamic changes of phospho-Stat1 level in lung cancer cells. Cytometry A 77: 1008-1019.
15. Chang RL, Yeh CH, Albitar M, (2010) Quantification of intracellular proteins and monitoring therapy using flow cytometry. Curr Drug Targets 11: 994-999.
16. Hale MB, Krutzik PO, Samra SS, Crane JM, Nolan GP, (2009) Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus. PLoS One 2009 4: e6756.
17. Galligan CL, Siebert JC, Siminovitch KA, Keystone EC, Bykerk V, et al. (2009) Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapy. PLoS One 4: e6703.
18. Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, et al. (1982): The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-24.
20. Gladman DD, Ibanez D, Urowitz MB, (2002) Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 29: 288-291.
21. Seo J, Shneiderman B, (2002) Interactively exploring hierarchical clustering results. Computer 35: 80-88.
22. Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, et al. (2004) Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol 22: 2053-2060.
23. Kotecha N, Flores NJ, Irish JM, Simonds EF, Sakai DS, et al. (2008) Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell 14: 335-343.
24. Brockman JL, Schroeder MD, Schuler LA, (2002) Prolactin activates the cyclin D1 promoter via the JAK2-STAT pathway. Mol Endocrinol 16: 774-784.
25. Brockman JL, Schuler LA, (2005) Prolactin signals via STAT5 and Oct-1 to the proximal cyclin D1 promoter. Mol Cell Endocrinol 239: 45-53.
26. Harada T, Kyttaris V, Li Y, Juang YT, Wang Y, et al. (2007) Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration. Autoimmunity 40: 1-8.
27. Lewis RS, Ward AC, (2008) STAT5 as a diagnostic marker for leukemia. Expert Rev Mol Diagn 8: 73-82.
28. Fleenor D, Arumugam R, Freemark M, (2006) Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm Res 66: 101-110.
29. Gutiérrez MA, Molina JF, Jara LJ, Garcia C, Gutiérrez-Ureña S, et al. (1996) Prolactin induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals. Int Arch Allergy Immunol 109: 229-235.
30. Jacobi AM, Rohde W, Ventz M, Burmester GR, Hiepe F, (2001) Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 10: 554-561.
31. Walker SE, (2001) Bromocriptine treatment of systemic lupus erythematosus. Lupus 10: 762-768.
32. Walker SE, Smarr KL, Parker JC, Weidensaul DN, Nelson W, et al. (2000) Mood states and disease activity in patients with systemic lupus erythematosus treated with bromocriptine. Lupus 9: 527-33.
33. Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, Sosa-Muñoz J, Miranda JM, et al. (1998) Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus 7: 414-9.